Cyclo Therapeutics Inc (CYTH) stock is lower by -19.29% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives CYTH stock a score of 35 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 42. CYTH's rank also includes a long-term technical score of 62.
CYTH has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on CYTH!
Cyclo Therapeutics Inc (CYTH) stock has gained 6.71% while the S&P 500 is lower by -0.41% as of 10:32 AM on Thursday, Aug 3. CYTH is up $0.10 from the previous closing price of $1.49 on volume of 133,707 shares. Over the past year the S&P 500 is higher by 8.17% while CYTH is lower by -19.29%. CYTH lost -$1.83 per share in the over the last 12 months.
Click Here to get the full Stock Report for Cyclo Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
